Literature DB >> 15944249

Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products.

Ingrid E Dumitriu1, Paramita Baruah, Barbara Valentinis, Reinhard E Voll, Martin Herrmann, Peter P Nawroth, Bernd Arnold, Marco E Bianchi, Angelo A Manfredi, Patrizia Rovere-Querini.   

Abstract

High mobility group box 1 (HMGB1) is an abundant and conserved nuclear protein that is released by necrotic cells and acts in the extracellular environment as a primary proinflammatory signal. In this study we show that human dendritic cells, which are specialized in Ag presentation to T cells, actively release their own HMGB1 into the extracellular milieu upon activation. This secreted HMGB1 is necessary for the up-regulation of CD80, CD83, and CD86 surface markers of human dendritic cells and for IL-12 production. The HMGB1 secreted by dendritic cells is also required for the clonal expansion, survival, and functional polarization of naive T cells. Using neutralizing Abs and receptor for advanced glycation end product-deficient (RAGE(-/-)) cells, we demonstrate that RAGE is required for the effect of HMGB1 on dendritic cells. HMGB1/RAGE interaction results in downstream activation of MAPKs and NF-kappaB. The use of an ancient signal of necrosis, HMGB1, by dendritic cells to sustain their own maturation and for activation of T lymphocytes represents a profitable evolutionary mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944249     DOI: 10.4049/jimmunol.174.12.7506

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  191 in total

1.  High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.

Authors:  Hulda Sigridur Hreggvidsdóttir; Anna M Lundberg; Ann-Charlotte Aveberger; Lena Klevenvall; Ulf Andersson; Helena Erlandsson Harris
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 2.  The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

3.  Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1.

Authors:  Roberto Romero; Tinnakorn Chaiworapongsa; Zeynep Alpay Savasan; Yi Xu; Youssef Hussein; Zhong Dong; Juan Pedro Kusanovic; Chong Jai Kim; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-09-29

4.  Potential role of high mobility group box protein 1 and intermittent PTH (1-34) in periodontal tissue repair following orthodontic tooth movement in rats.

Authors:  M Wolf; S Lossdörfer; N Abuduwali; A Jäger
Journal:  Clin Oral Investig       Date:  2012-07-10       Impact factor: 3.573

Review 5.  Regulation of Posttranslational Modifications of HMGB1 During Immune Responses.

Authors:  Yiting Tang; Xin Zhao; Daniel Antoine; Xianzhong Xiao; Haichao Wang; Ulf Andersson; Timothy R Billiar; Kevin J Tracey; Ben Lu
Journal:  Antioxid Redox Signal       Date:  2016-02-05       Impact factor: 8.401

Review 6.  HMGB1 release by inflammasomes.

Authors:  Lieselotte Vande Walle; Thirumala-Dev Kanneganti; Mohamed Lamkanfi
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

7.  Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation.

Authors:  Kempaiah Rayavara; Alexander Kurosky; Susan J Stafford; Nisha J Garg; Allan R Brasier; Roberto P Garofalo; Yashoda M Hosakote
Journal:  J Immunol       Date:  2018-10-01       Impact factor: 5.422

Review 8.  Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies.

Authors:  Samuel T Workenhe; Karen L Mossman
Journal:  Mol Ther       Date:  2013-10-19       Impact factor: 11.454

9.  The Free Radical Scavenger NecroX-7 Attenuates Acute Graft-versus-Host Disease via Reciprocal Regulation of Th1/Regulatory T Cells and Inhibition of HMGB1 Release.

Authors:  Keon-Il Im; Nayoun Kim; Jung-Yeon Lim; Young-Sun Nam; Eun-Sol Lee; Eun-Jung Kim; Hyoung Jin Kim; Soon Ha Kim; Seok-Goo Cho
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

10.  RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes.

Authors:  Ana M Avalos; Kerstin Kiefer; Jane Tian; Sean Christensen; Mark Shlomchik; Anthony J Coyle; Ann Marshak-Rothstein
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.